{
    "url_original": "https://www.wsj.com/articles/novavax-says-early-data-shows-covid-19-vaccine-protects-against-omicron-11640211910?mod=business_lead_pos3",
    "url": "novavax-says-early-data-shows-covid-19-vaccine-protects-against-omicron-11640211910",
    "title": "Novavax Says Early Data Shows Covid-19 Vaccine Protects Against Omicron",
    "sub_head": "Maryland-based company prepares to make Omicron-specific vaccine",
    "category_1": "Business",
    "image_1_url": "https://images.wsj.net/im-457210?width=860&height=573",
    "image_1": "im-457210.jpg",
    "time": "2021-12-22 18:01:00",
    "body": "Novavax Inc.  said its two-dose Covid-19 vaccine demonstrated “strong immune responses” against the Omicron variant and other variants of the coronavirus, citing initial data.<br />Still, the company said neutralization against the Omicron variant was “4-fold lower” than it was against the original strain of the virus, suggesting that a booster shot or a new Omicron-specific vaccine would be beneficial."
}